Perbak Capital Partners’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-58,330
Closed -$8.55M 269
2026
Q1
$8.55M Buy
+58,330
New +$9M 2.1% 10
2025
Q4
Sell
-173,368
Closed -$24.1M 331
2025
Q3
$24.1M Buy
173,368
+56,369
+48% +$7.63M 4.25% 5
2025
Q2
$15.8M Buy
116,999
+90,549
+342% +$12.2M 3.57% 6
2025
Q1
$3.86M Buy
26,450
+1,014
+4% +$147K 2.86% 5
2024
Q4
$3.5M Buy
25,436
+7,736
+44% +$1.13M 1.87% 10
2024
Q3
$2.73M Sell
17,700
-72,108
-80% -$10.9M 1.91% 15
2024
Q2
$13.1M Buy
+89,808
New +$12.9M 3.87% 6

Other funds holding XLV

Perbak Capital Partners's XLV Position: Q2 2026 in Review

Perbak Capital Partners sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q2 2026, closing a stake of 58,330 shares — an estimated $8.55M sold.

Perbak Capital Partners first reported a position in XLV in Q2 2024 and held it in 7 quarters. The position peaked at $24.1M in Q3 2025. 1,856 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Perbak Capital Partners reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q2 2026 after selling out during the quarter.
  • Perbak Capital Partners sold 58,330 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $8.55M.
  • Perbak Capital Partners first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2024 and held it in 7 quarters.
  • Perbak Capital Partners's State Street Health Care Select Sector SPDR ETF position peaked at $24.1M in Q3 2025.
  • 1,856 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Perbak Capital Partners's 13F filing for Q2 2026.